| Pre-procedure | |
| Age in years (mean [SD]) | 65.5 (±10.8) |
| Male (n [%]) | 30 (78.9) |
| BMI (SD) | 22.7 (±2.4) |
| Stupor (n [%]) | 21 (55.3) |
| Hypertension (n [%]) | 35 (92.1) |
| Smoking (n [%]) | 27 (71.1) |
| Hyperlipidemia (n [%]) | 7 (18.4) |
| Diabetes mellitus (n [%]) | 14 (36.8) |
| IV alteplase (n [%]) | 3 (7.9) |
| Onset-to-door time in hours (mean [SD]) | 6.3 (±4.5) |
| Severe stroke (n [%]) | 3 (7.9) |
| NIHSS (mean [SD]) | 16.7 (±3.7) |
| pc-ASPECTS (mean [SD]) | 6.7 (±1.1) |
| Procedure | |
| Tandem occlusions (n [%]) | 8 (21.1) |
| Procedural time in mins (mean [SD]) | 88.6 (±45.7) |
| Self-expanding stents (n [%]) | 24 (63.2) |
| First balloon length in mm (mean [SD]) | 15.3 (±2.1) |
| First balloon diameter in mm (mean [SD]) | 2.2 (±0.3) |
| Stent length in mm (mean [SD]) | 18.6 (±6.1) |
| Stent diameter in mm (mean [SD]) | 3.7 (±0.6) |
| Second balloon length in mm (mean [SD]) | 13.3 (±2.4) |
| Second balloon diameter in mm (mean [SD]) | 2.8 (±0.8) |
| Dilator device to cross VA ostium occlusion (n [%]) | 3 (7.9) |
| MT to cross isolated lesion (n [%]) | 21 (55.3) |
| Post-procedure | |
| Post-procedural sedation (n [%]) | 20 (52.6) |
| Length of stay in ICU in days (mean [SD]) | 7.4 (±7.3) |
| Length of hospital stay in days (mean [SD]) | 15.5 (±10.4) |
| Stroke rehabilitation (n [%]) | 24 (63.2) |
| External ventricular drainage (n (%]) | 1 (2.6%) |